Anthrax shots before attack not worthwhile: report
|
Tweet
|
|
Vaccinating an entire population against anthrax before there is an immediate threat of a biological warfare attack is not cost-effective, results of statistical analysis suggest.
If an attack does occur, mass vaccinations plus administration of antibiotics would be the best strategy, Dr. Robert A. Fowler at the University of Toronto in Canada and colleagues explain in their report in the Annals of Internal Medicine.
The authors compared the costs, harms and benefits of offering vaccination or antibiotics to a hypothetical cohort of people in a large metropolitan city.
They assumed that the yearly probability of an attack is 1 percent, that 10 percent of the population would have sufficient exposure to anthrax spores to cause clinical disease, and that 95 percent of these would develop severe inhalational anthrax unless given antibiotics or a vaccine.
A combination strategy of three vaccinations administered 2 weeks apart and antibiotics after an attack would prevent more cases of Anthrax and more deaths than either approach alone, the team calculated. It would also save $355 per person compared with vaccination alone.
No preventative measures at all would be the most expensive strategy, the investigators note, because of the high cost of treating inhalational anthrax.
“These findings highlight the critical need for distribution systems that can rapidly provide prophylaxis and vaccination for hundreds of thousands, perhaps millions, of exposed people,” Fowler and colleagues conclude.
Dr. Glenn F. Webb, at Vanderbilt University in Nashville, Tennessee, says in an accompanying editorial that the researchers did an excellent job analyzing the policy issues of an attack, but “they may underestimate the incalculable societal impact of such an attack,” which might result in social panic and chaos.
Webb says measures such as implementation of technology to detect the release of anthrax spores, stockpiling of emergency supplies, and scientific research into the development of vaccines, antibiotics, and antidotes “are imperative.”
SOURCE: Annals of Internal Medicine, April 19, 2005.
Revision date: June 21, 2011
Last revised: by Andrew G. Epstein, M.D.
| RELATED STORIES: | ||
| Comments | [ + Post Your Own ] |
Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.
There are no comments for this entry yet. [ + Comment here + ]
We are pleased to let readers post comments about an article. Please increase the credibility of your post by including your full name and email.
All comments are reviewed by our editors before they are posted on the site. Just keep it clean, kids.
- Full Story - - »»»
Exercise tied to lower risk of psoriasis: study
- Full Story - - »»»
Severe Gum Disease, Impotence May Be Linked
- Full Story - - »»»
New Blood Thinner May Lower Chances of Clots in High-Risk Heart Patients: FDA
- Full Story - - »»»
Heart Damage After Chemo Linked to Stress in Cardiac Cells
- Full Story - - »»»
Viewers’ family background affects how they react to MTV shows ‘16 and Pregnant,’ ‘Teen Mom’
- Full Story - - »»»
Weight management in pregnancy with diet is beneficial and safe and can reduce complications
- Full Story - - »»»

